Is your organization ready to comply with the updated requirements of the Drug Supply Chain Security Act (DSCSA)? Effective November 24, 2024, the FDA DSCSA mandates the use of an electronic, interconnected platform to trace prescription medications throughout the U.S. supply chain. This critical update aims to safeguard patients by preventing counterfeit or harmful drugs from reaching them.
This whitepaper highlights the complexities of compliance, including electronic-only tracking of transaction data, new responsibilities for trading partners, and the critical role of GS1 Standards (EPCIS) in ensuring seamless data exchange. With potential penalties for non-compliance ranging from hefty fines to criminal liability, organizations must adapt their operations to remain compliant.
Advis provides key insights into operational changes, including updating SOPs, integrating software solutions, and leveraging standardized systems for secure and efficient medication tracking.
Download the full whitepaper now to secure your supply chain and ensure compliance with these transformative regulations!
Contact Advis today via our website here or by phone at (708) 478-7030 to learn more about the DSCSA standards or to perform a review of your current operations.
Published: December 11, 2024
